BioCentury
ARTICLE | Clinical News

Hemispherx preclinical data

September 30, 2013 7:00 AM UTC

In vitro, Alferon N Injection and Tamiflu oseltamivir each significantly inhibited wild-type H7N9 influenza virus and led to similar reductions in wild-type H7N9 influenza titer after 48 hours of treatment exposure. Hemispherx also said Alferon N Injection significantly inhibited Tamiflu-resistant H7N9 influenza virus. Data were presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver. The company could not be reached for next steps. ...